Covid DiariesJust In

Covid-19: AstraZeneca vaccine study put on hold after one illness

Vishnu Vasisht

AstraZeneca vaccine

Amidst the Coronavirus crisis, America's AstraZeneca company was soon to deliver good news, but for now, the world has suffered a major setback. AstraZeneca has given a pause to its last-stage vaccine trial. AstraZeneca's vaccine trial has been stopped after a volunteer involved in the human trial fell ill. AstraZeneca has issued a statement saying that it is a routine interruption as not much has been known about the person involved in the trial yet. It will be reviewed well and only then will the trial resume.

According to the report of the health news website State News, a volunteer participating in the trial has seen serious adverse reactions suspected of the vaccine and in view of this, it has been decided to stop the trial of the last phase of the vaccine. AstraZeneca Covid, a drug development company with the University of Oxford, is at the forefront of the global race for the vaccine.

However, a detailed explanation of what the case was and when the adverse reaction to the vaccine was reported could not be known.

A statement from the spokesperson for AstraZeneca states that 'large trials will coincidentally have the disease, but it should be reviewed independently to be carefully examined.'

As of now, AstraZeneca has not commented on it yet. Although nine major U.S. And European vaccine developers on Tuesday resolved to maintain scientific safety and efficacy standards for their experimental vaccines despite the emergency to control the Coronavirus epidemic. They said that the vaccine is urgently needed, but we will not compromise on its standards and effectiveness. By all means, we will approve the vaccine only after testing.

Read Next | India’s COVID-19 vaccine COVAXIN may get permission before completion of clinical trial

Comment here